These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33768226)

  • 1. Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States.
    Venkatesh KK; Morrison L; Tuomala RE; Stek A; Read JS; Shapiro DE; Livingston EG
    Clin Infect Dis; 2021 Sep; 73(6):969-978. PubMed ID: 33768226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.
    Venkatesh KK; Morrison L; Livingston EG; Stek A; Read JS; Shapiro DE; Tuomala RE
    Obstet Gynecol; 2018 May; 131(5):879-890. PubMed ID: 29630021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between maternal human immunodeficiency virus infection and preterm birth: A matched case-control study from a pregnancy outcome registry.
    Elenga N; Djossou FÉL; Nacher M
    Medicine (Baltimore); 2021 Jan; 100(4):e22670. PubMed ID: 33530154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.
    Jao J; Kacanek D; Williams PL; Geffner ME; Livingston EG; Sperling RS; Patel K; Bardeguez AD; Burchett SK; Chakhtoura N; Scott GB; Van Dyke RB; Abrams EJ; ;
    Clin Infect Dis; 2017 Sep; 65(6):982-989. PubMed ID: 28575201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
    Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
    Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery After 40 Weeks of Gestation in Pregnant Women With Well-Controlled Human Immunodeficiency Virus.
    Scott RK; Chakhtoura N; Burke MM; Cohen RA; Kreitchmann R
    Obstet Gynecol; 2017 Sep; 130(3):502-510. PubMed ID: 28796679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
    AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 May; 21(8):1019-26. PubMed ID: 17457096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.